Microfluidic platform for characterizing TCR–pMHC interactions
Max A. Stockslager(Massachusetts Institute of Technology), Scott R. Manalis(Massachusetts Institute of Technology), Kevin Hu(Oberlin College), Edgar Aranda‐Michel(Massachusetts Institute of Technology), Vivian Hecht(Massachusetts Institute of Technology), Robert Kimmerling(Massachusetts Institute of Technology), Josephine Bagnall(Broad Institute), Kristofor R. Payer(Massachusetts Institute of Technology)
Cited by 15
Related Papers
Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer
|Cell|2021|586
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
|Molecular Cancer|2014|559
A comparison of microfluidic methods for high-throughput cell deformability measurements
|Nature Methods|2020|286
Targeting minimal residual disease: a path to cure?
|Nature reviews. Cancer|2018|164
Deformability of Tumor Cells versus Blood Cells
|Scientific Reports|2015|142